Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion

作者:Du Four Stephanie; Maenhout Sarah K; Benteyn Daphne; De Keersmaecker Brenda; Duerinck Johnny; Thielemans Kris; Neyns Bart; Aerts Joeri L
来源:Cancer Immunology, Immunotherapy, 2016, 65(6): 727-740.
DOI:10.1007/s00262-016-1836-3